Lv1
30 积分 2024-02-28 加入
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
2天前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
2天前
已完结
Ablation of FAS confers allogeneic CD3–CAR T cells with resistance to rejection by T cells and natural killer cells
2天前
已完结
CD19 Antigen Density Down-Regulation at Time of Progression in Large B-Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel
10天前
已关闭
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
11天前
已完结
PD‑L1 engagement on T cells promotes self‑tolerance and suppression of neighboring macrophages and effector T cells in cancer
12天前
已完结
Teclistamab-induced remission in refractory systemic lupus erythematosus
16天前
已完结
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis
17天前
已完结
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis
17天前
已关闭
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis
17天前
已关闭
皖公网安备34019202002308
